Nr 508 exam Study guides, Class notes & Summaries

NR 508 ADVANCED PHARM. FINAL EXAM 2023 NEW (JAN-JULY TERM) PRIORITY EXAM WITH RATIONALE 100% - A 5-year-old child who has no previous history of otitis media is seen in clinic with a temperature of 100° F. The primary care NP visualizes bilateral erythematous, non-bulging, intact tympanic membranes. The child is taking fluids well and is playing with toys in the examination room. The NP should:

Final NR 508 Exam Questions and Answers 100% CorrectFinal NR 508 Exam Questions and Answers 100% CorrectFinal NR 508 Exam Questions and Answers 100% Correct Nurse practitioner prescriptive authority is regulated by: - ANSWER-The State Board of Nursing for each state The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber include: - ANSWER-Nurses care for the patient from a holistic approach and include the patient in decision making regarding their care....

Advanced Pathophysiology NR 508 Module 8 Exam Questions and Correct Answers A perimenopausal woman tells the primary care NP that she is having hot flashes and increasingly severe mood swings. The woman has had a hysterectomy. The NP should prescribe:

NR 508 Exam 1 Latest Update Graded A Childhood HL rates 3:1000 children have hearing loss in the US, 10:1000 school-aged children have hearing loss, and 190:1000 teens have hearing loss. The increase in rate is because hearing loss can be acquired at any age and because methods of screening/detection are not perfect and miss children, especially those with lower degrees of loss. Parameters of hearing loss degree of loss and age inform the child's needs and how we interact with them. a...

ADVANCED PHARMACOLOGY-NR 508 EXAM REVIEW 2023/2024 effectiveness, safety, selectivity - CORRECT ANSWER-State the three (3) most important characteristics of any drug. No, all medications have side effects - CORRECT ANSWER-Is it possible to have a selective drug? Absorption, distribution, metabolism and excretion - CORRECT ANSWER-Define the four phases of pharmacokenetics. The nature and intensity of the response the drug has on the body - CORRECT ANSWER-Define pharmacodynamics. Evalu...

NR 508 Edmunds Pharmacology Final Exam || All Questions & Answers (100% Verified) NR 508 Edmunds Pharmacology Final Exam || All Questions & Answers (100% Verified) 1st line treatment for HTN (non-black, no CKD) - ANSWER - ACEI (arb), thiazide, ccb 1st line treatment for HTN for black pts (no ckd) - ANSWER - thiazide, ccb 1st line option for HTN for anyone with CKD - ANSWER - ACEI (arb) Types of diuretics - ANSWER - thiazides, loop diuretics, k-sparing preferred diuretic with rena...

QUIZ 7 NR 508 EXAM QUESTIONS AND ANSWERS 100% CORRECTQUIZ 7 NR 508 EXAM QUESTIONS AND ANSWERS 100% CORRECTQUIZ 7 NR 508 EXAM QUESTIONS AND ANSWERS 100% CORRECTQUIZ 7 NR 508 EXAM QUESTIONS AND ANSWERS 100% CORRECT Digoxin levels need to be monitored closely when the following medication is started: - ANSWER-Albuterol Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis? - ANSWER-Beta-2 agonists Haro...

NR 508 ADVANCED PHARMACOLOGY. FINAL EXAM 2023 NEW (JAN-JULY TERM) PRIORITY EXAM WITH RATIONALE 100% NR 508 ADVANCED PHARMACOLOGY. FINAL EXAM 2023 NEW (JAN-JULY TERM) PRIORITY EXAM WITH RATIONALE 100%

NR 508 PHARM WEEK 8 EXAM | QUESTIONS & ANSWERS (VERIFIED) | LATEST UPDATE | GRADED A+NR 508 PHARM WEEK 8 EXAM | QUESTIONS & ANSWERS (VERIFIED) | LATEST UPDATE | GRADED A+NR 508 PHARM WEEK 8 EXAM | QUESTIONS & ANSWERS (VERIFIED) | LATEST UPDATE | GRADED A+

NR 508 Final Exam 2024 Questions and Answers (Graded A)NR 508 Final Exam 2024 Questions and Answers (Graded A)NR 508 Final Exam 2024 Questions and Answers (Graded A)NR 508 Final Exam 2024 Questions and Answers (Graded A) Know Initial treatment choices for HTN - ANSWER-Diuretics, beta blockers, calcium channel blockers, ace inhibitors and angiotensin II (ARB's) Know first line treatment options for HTN for African Americans without renal impairment. - ANSWER-Calcium Channel Blockers with a t...